Cargando…

HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study

This paper reports a novel strategy based on high-speed counter-current chromatography (HSCCC) technique to separate in vivo metabolites from refined extract of urine after administration of an herbal medicine. Saussurea laniceps (SL) was chosen as a model herbal medicine to be used to test the feas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Tao, Zhu, Lin, Zhu, Guo-Yuan, Tang, Yi-Na, Xu, Jun, Fan, Jia-Yi, Zhao, Zhong-Zhen, Chen, Hu-Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020495/
https://www.ncbi.nlm.nih.gov/pubmed/27618988
http://dx.doi.org/10.1038/srep33036
_version_ 1782453213980524544
author Yi, Tao
Zhu, Lin
Zhu, Guo-Yuan
Tang, Yi-Na
Xu, Jun
Fan, Jia-Yi
Zhao, Zhong-Zhen
Chen, Hu-Biao
author_facet Yi, Tao
Zhu, Lin
Zhu, Guo-Yuan
Tang, Yi-Na
Xu, Jun
Fan, Jia-Yi
Zhao, Zhong-Zhen
Chen, Hu-Biao
author_sort Yi, Tao
collection PubMed
description This paper reports a novel strategy based on high-speed counter-current chromatography (HSCCC) technique to separate in vivo metabolites from refined extract of urine after administration of an herbal medicine. Saussurea laniceps (SL) was chosen as a model herbal medicine to be used to test the feasibility of our proposed strategy. This strategy succeeded in the case of separating four in vivo metabolites of SL from the urine of rats. Briefly, after oral administration of SL extract to three rats for ten days (2.0 g/kg/d), 269.1 mg of umbelliferone glucuronide (M1, purity, 92.5%), 432.5 mg of scopoletin glucuronide (M2, purity, 93.2%), 221.4 mg of scopoletin glucuronide (M3, purity, 92.9%) and 319.0 mg of scopoletin glucuronide (M4, purity, 90.4%) were separated from 420 mL of the rat urine by HSCCC using a two-phase solvent system composed of methyl tert-butyl ether–n-butanol–acetonitrile–water (MTBE–n-BuOH–ACN–H(2)O) at a volume ratio of 10:30:11:49. The chemical structures of the four metabolites, M1 to M4, were confirmed by MS and (1)H, (13)C NMR. As far as we know, this is the first report of the successful separation of in vivo metabolites by HSCCC after administration of an herbal medicine.
format Online
Article
Text
id pubmed-5020495
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50204952016-09-20 HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study Yi, Tao Zhu, Lin Zhu, Guo-Yuan Tang, Yi-Na Xu, Jun Fan, Jia-Yi Zhao, Zhong-Zhen Chen, Hu-Biao Sci Rep Article This paper reports a novel strategy based on high-speed counter-current chromatography (HSCCC) technique to separate in vivo metabolites from refined extract of urine after administration of an herbal medicine. Saussurea laniceps (SL) was chosen as a model herbal medicine to be used to test the feasibility of our proposed strategy. This strategy succeeded in the case of separating four in vivo metabolites of SL from the urine of rats. Briefly, after oral administration of SL extract to three rats for ten days (2.0 g/kg/d), 269.1 mg of umbelliferone glucuronide (M1, purity, 92.5%), 432.5 mg of scopoletin glucuronide (M2, purity, 93.2%), 221.4 mg of scopoletin glucuronide (M3, purity, 92.9%) and 319.0 mg of scopoletin glucuronide (M4, purity, 90.4%) were separated from 420 mL of the rat urine by HSCCC using a two-phase solvent system composed of methyl tert-butyl ether–n-butanol–acetonitrile–water (MTBE–n-BuOH–ACN–H(2)O) at a volume ratio of 10:30:11:49. The chemical structures of the four metabolites, M1 to M4, were confirmed by MS and (1)H, (13)C NMR. As far as we know, this is the first report of the successful separation of in vivo metabolites by HSCCC after administration of an herbal medicine. Nature Publishing Group 2016-09-13 /pmc/articles/PMC5020495/ /pubmed/27618988 http://dx.doi.org/10.1038/srep33036 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Yi, Tao
Zhu, Lin
Zhu, Guo-Yuan
Tang, Yi-Na
Xu, Jun
Fan, Jia-Yi
Zhao, Zhong-Zhen
Chen, Hu-Biao
HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study
title HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study
title_full HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study
title_fullStr HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study
title_full_unstemmed HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study
title_short HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study
title_sort hsccc-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: saussurea laniceps, a case study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020495/
https://www.ncbi.nlm.nih.gov/pubmed/27618988
http://dx.doi.org/10.1038/srep33036
work_keys_str_mv AT yitao hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy
AT zhulin hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy
AT zhuguoyuan hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy
AT tangyina hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy
AT xujun hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy
AT fanjiayi hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy
AT zhaozhongzhen hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy
AT chenhubiao hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy